Nutrition Supplements for Trauma
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests whether a special protein drink, Nutrition Supplements - Fresubin KCAL Drinks, can aid older adults in recovering after a traumatic injury. Participants will either receive the protein drinks or follow regular dietary advice. The study aims to determine if the extra protein improves energy use, body composition, and muscle mass. It suits trauma patients over 45 who can eat normally and had a CT scan during their hospital stay. As an unphased trial, this study offers participants a unique opportunity to contribute to understanding the potential benefits of protein supplements in recovery.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on adding nutrition supplements, so you may not need to stop your medications, but it's best to check with the trial organizers.
Is there any evidence suggesting that this trial's treatments are likely to be safe?
Research shows that nutritional supplements like Fresubin KCAL Drinks are generally safe for most people. Although specific safety data for Fresubin KCAL Drinks is unavailable, other studies suggest that nutrition delivered directly to the stomach is usually well-tolerated. Hospitals often use these supplements to provide patients with necessary energy and protein, especially when they are very sick.
Some studies have found that these supplements can reduce issues like diarrhea without introducing other risks. In general, supplements support health by providing essential nutrients when a regular diet falls short. While specific data on Fresubin KCAL Drinks is limited, similar products have been safely used to enhance nutrition in hospital patients.12345Why are researchers excited about this trial?
Researchers are excited about the use of Fresubin KCAL Drinks for trauma nutrition because they offer enhanced protein supplementation tailored to individual needs. Unlike the standard nutrition care, which provides general guidance without precise caloric measurements, this approach uses indirect calorimetry to adjust protein intake, potentially optimizing recovery. This personalized method could lead to better outcomes for trauma patients by ensuring they receive the exact nutrition their bodies need to heal efficiently.
What evidence suggests that nutrition supplements could be effective for trauma patients?
Research has shown that early nutritional support, including adequate calories and protein, can reduce the risk of death in trauma patients. In this trial, participants in the Enhanced Protein Supplementation arm will receive high-protein, energy-rich drinks, such as Fresubin KCAL, which have increased body cell mass in previous studies. These drinks can enhance the body's strength and recovery. Critically ill patients often lack sufficient protein and calories, so these drinks help meet their nutritional needs. Overall, incorporating these drinks can significantly aid recovery for older trauma patients.12367
Who Is on the Research Team?
Paul Wischmeyer, MD
Principal Investigator
Duke University
Are You a Good Fit for This Trial?
This trial is for older adults who have experienced trauma or critical illness and are in need of nutritional support. Participants must be able to consume oral nutrition supplements and follow the study protocol both during their hospital stay and for four weeks after discharge.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive either enhanced protein supplementation or standard nutrition care during hospitalization and for 4 weeks post-discharge
Follow-up
Participants are monitored for changes in body composition, muscle strength, and functional outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Nutrition Supplements - Fresubin KCAL Drinks
Find a Clinic Near You
Who Is Running the Clinical Trial?
Duke University
Lead Sponsor